Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation

被引:57
作者
Hahn, MK
Mazei-Robison, MC
Blakely, RD
机构
[1] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA
关键词
D O I
10.1124/mol.105.011270
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of norepinephrine ( NE) in attention, memory, affect, stress, heart rate, and blood pressure implicates NE in psychiatric and cardiovascular disease. The norepinephrine transporter (NET) mediates reuptake of released catecholamines, thus playing a role in the limitation of signaling strength in the central and peripheral nervous systems. Nonsynonymous single nucleotide polymorphisms (SNPs) in the human NET (hNET) gene that influence transporter function can contribute to disease, such as the nonfunctional transporter, A457P, identified in orthostatic intolerance. Here, we examine additional amino acid variants that have been identified but not characterized in populations that include cardiovascular phenotypes. Variant hNETs were expressed in COS-7 cells and were assayed for protein expression and trafficking using cell-surface biotinylation and Western blot analysis, transport of radiolabeled substrate, antagonist interaction, and regulation through protein kinase C (PKC)-linked pathways by the phorbol ester beta-phorbol-12-myristate- 13-acetate. We observed functional perturbations in 6 of the 10 mutants studied. Several variants were defective in trafficking and transport, with the most dramatic effect observed for A369P, which was completely devoid of the fully glycosylated form of transporter protein, was retained intracellularly, and lacked any transport activity. Furthermore, A369P and another trafficking variant, N292T, impeded surface expression of hNET when coexpressed. F528C demonstrated increased transport and, remarkably, exhibited both insensitivity to down-regulation by PKC and a decrease in potency for the tricyclic antidepressant desipramine. These findings reveal functional deficits that are likely to compromise NE signaling in SNP carriers in the population and identify key regions of NET contributing to transporter biosynthesis, activity, and regulation.
引用
收藏
页码:457 / 466
页数:10
相关论文
共 44 条
[1]   Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition [J].
Adkins, EM ;
Barker, EL ;
Blakely, RD .
MOLECULAR PHARMACOLOGY, 2001, 59 (03) :514-523
[2]  
Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P744
[3]  
Barker EL, 1996, MOL PHARMACOL, V50, P957
[4]  
BARKER EL, 1994, MOL PHARMACOL, V46, P799
[5]   Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder [J].
Biederman, J ;
Spencer, T .
BIOLOGICAL PSYCHIATRY, 1999, 46 (09) :1234-1242
[6]   Physiological genomics of antidepressant targets: Keeping the periphery in mind [J].
Blakely, RD .
JOURNAL OF NEUROSCIENCE, 2001, 21 (21) :8319-8323
[7]   CHIMERIC DOPAMINE NOREPINEPHRINE TRANSPORTERS DELINEATE STRUCTURAL DOMAINS INFLUENCING SELECTIVITY FOR CATECHOLAMINES AND 1-METHYL-4-PHENYLPYRIDINIUM [J].
BUCK, KJ ;
AMARA, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12584-12588
[8]  
FULLER RW, 1983, RES COMMUN CHEM PATH, V41, P169
[9]   Patch-clamp and amperometric recordings from norepinephrine transporters: Channel activity and voltage-dependent uptake [J].
Galli, A ;
Blakely, RD ;
DeFelice, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13260-13265
[10]  
GRESCH PJ, 1995, J NEUROCHEM, V65, P111